APOL1 Genotype and Glomerular and Tubular Kidney Injury in Women With HIV

Am J Kidney Dis. 2015 Jun;65(6):889-98. doi: 10.1053/j.ajkd.2015.02.329. Epub 2015 Apr 24.

Abstract

Background: APOL1 genotype is associated with advanced kidney disease in African Americans, but the pathogenic mechanisms are unclear. Here, associations of APOL1 genotype with urine biomarkers of glomerular and tubular injury and kidney function decline were evaluated.

Study design: Observational study.

Setting & participants: 431 human immunodeficiency virus (HIV)-infected African American women enrolled in Women's Interagency HIV Study (WIHS).

Predictor: APOL1 genotype.

Outcomes: Albumin-creatinine ratio (ACR), 4 tubular injury biomarkers (interleukin 18 [IL-18], kidney injury molecule 1 [KIM-1], neutrophil gelatinase-associated lipocalin [NGAL], and α1-microglobulin [A1M]), and kidney function estimated using the CKD-EPI cystatin C equation.

Measurements: Participants were genotyped for APOL1 single-nucleotide polymorphisms rs73885319 (G1 allele) and rs71785313 (G2 allele). Urine biomarkers were measured using stored samples from 1999-2000. Cystatin C was measured using serum collected at baseline and 4- and 8-year follow-ups.

Results: At baseline, ACRs were higher among 47 women with 2 APOL1 risk alleles versus 384 women with 0/1 risk allele (median, 24 vs 11mg/g; P<0.001). Compared with women with 0/1 risk allele, women with 2 risk alleles had 104% higher ACRs (95% CI, 29-223mg/g) and 2-fold greater risk of ACR>30 (95% CI, 1.17-3.44) mg/g after multivariable adjustment. APOL1 genotype showed little association with urine IL-18:Cr ratio, KIM-1:Cr ratio, and NGAL:Cr ratio (estimates of -5% [95% CI, -24% to 18%], -20% [95% CI, -36% to -1%], and 10% [95% CI, -26% to 64%], respectively) or detectable urine A1M (prevalence ratio, 1.13; 95% CI, 0.65-1.97) in adjusted analyses. Compared with women with 0/1 allele, women with 2 risk alleles had faster eGFR decline, by 1.2 (95% CI, 0.2 to 2.2) mL/min/1.73m(2) per year, and 1.7- and 3.4-fold greater rates of incident chronic kidney disease (95% CI, 1.1 to 2.5) and 10% annual eGFR decline (95% CI, 1.7 to 6.7), respectively, with minimal attenuation after adjustment for glomerular and tubular injury biomarker levels.

Limitations: Results may not be generalizable to men.

Conclusions: Among HIV-infected African American women, APOL1-associated kidney injury appears to localize to the glomerulus, rather than the tubules.

Keywords: APOL1 genotype; African American; G1 allele; G2 allele; Women’s Interagency HIV Study (WIHS); albumin-creatinine ratio (ACR); apolipoprotein L1; glomerular injury; kidney disease; proteinuria; renal function; risk allele; risk variant; single-nucleotide polymorphism (SNP); tubular injury biomarker.

Publication types

  • Observational Study
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acute-Phase Proteins / metabolism
  • Adult
  • Albuminuria / metabolism
  • Alpha-Globulins / metabolism
  • Apolipoprotein L1
  • Apolipoproteins / genetics*
  • Black or African American / genetics*
  • Case-Control Studies
  • Creatinine / metabolism
  • Female
  • Genetic Predisposition to Disease
  • Genotype
  • HIV Infections / complications*
  • Hepatitis A Virus Cellular Receptor 1
  • Humans
  • Interleukin-18 / metabolism
  • Kidney Glomerulus / metabolism*
  • Kidney Tubules / metabolism*
  • Lipocalin-2
  • Lipocalins / metabolism
  • Lipoproteins, HDL / genetics*
  • Membrane Glycoproteins / metabolism
  • Middle Aged
  • Polymorphism, Single Nucleotide
  • Prospective Studies
  • Proto-Oncogene Proteins / metabolism
  • Receptors, Virus / metabolism
  • Renal Insufficiency, Chronic / complications
  • Renal Insufficiency, Chronic / genetics*
  • Renal Insufficiency, Chronic / metabolism
  • Serum Albumin

Substances

  • APOL1 protein, human
  • Acute-Phase Proteins
  • Alpha-Globulins
  • Apolipoprotein L1
  • Apolipoproteins
  • HAVCR1 protein, human
  • Hepatitis A Virus Cellular Receptor 1
  • Interleukin-18
  • LCN2 protein, human
  • Lipocalin-2
  • Lipocalins
  • Lipoproteins, HDL
  • Membrane Glycoproteins
  • Proto-Oncogene Proteins
  • Receptors, Virus
  • Serum Albumin
  • Creatinine